Travere Therapeutics Eulerpool News

Travere Therapeutics Aktie News

Travere Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Travere Therapeutics News stellen wir hier zusammen.

• 13. Juni ·

  Yahoo
  HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs
• 11. Juni ·

  Yahoo
  Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 15th International Podocyte Conference
• 10. Juni ·

  Yahoo
  Travere Therapeutics Launches "Play It Forward" Campaign to Celebrate the FSGS Community on Inaugural Awareness Day
• 23. Mai ·

  Yahoo
  England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy
• 15. Mai ·

  Yahoo
  Travere Therapeutics Announces FDA Acceptance of sNDA for FILSPARI® (sparsentan) in FSGS
• 13. Mai ·

  Yahoo
  Verrica Pharmaceuticals Reports Quarterly 2025 Financial Results
• 29. April ·

  Yahoo
  Travere Therapeutics and CSL Vifor Announce Standard EU Approval of FILSPARI® (sparsentan) for IgA Nephropathy
• 29. April ·

  Yahoo
  CSL Vifor and Travere Therapeutics announce standard EU approval for FILSPARI® in IgA Nephropathy
• 24. April ·

  Yahoo
  Travere Therapeutics to Report First Quarter 2025 Financial Results
• 23. April ·

  Yahoo
  Exploring 3 High Growth Tech Stocks In The US Market